To evaluate the outcomes of early second-look surgery for residual tumors in diffuse glioma patients following initial resection, highlighting its significance in improving patient management.
Key Findings:
46 patients underwent early second-look surgery for residual tumor.
Removal of > 95% of tumor volume post-re-resection is prognostic for survival, indicating a potential target for surgical intervention.
Early re-resection may improve progression-free survival and overall survival, suggesting a need for careful patient selection.
Interpretation:
Early second-look surgery for residual tumors in diffuse glioma patients can be a viable option to enhance survival outcomes, though careful consideration of surgical risks, including potential neurological deficits, is necessary.
Limitations:
Retrospective design may introduce selection bias.
Small sample size limits generalizability of findings.
No predefined volumetric threshold for re-resection decisions, which may affect consistency in treatment.
Conclusion:
Early second-look surgery for residual tumors in diffuse glioma patients shows promise in improving survival, warranting further investigation in larger cohorts, particularly focusing on long-term outcomes and quality of life.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
